[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100497755":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":37,"responsibleParty":54,"collaborators":31,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":31,"eligibilityCriteria":61,"healthyVolunteers":58,"sex":62,"minAge":63,"maxAge":31,"enrollmentInfo":64,"targetDuration":31,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":40,"whyStopped":31,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Al18F-PSMA-BCH PET\u002FCT","EXPERIMENTAL","Al18F-PSMA-BCH PET\u002FCT will be performed on patients with suspected or clearly diagnosed PSMA positive-expressing tumors.（including prostate cancer, transitional epithelial carcinoma, colon carcinoma, adenoid cystadenocarcinoma, mesothelioma, hepatocellular carcinoma, cholangiocellular carcinoma, multiple myeloma, etc.）",[13],"Drug: Al18F-PSMA-BCH PET\u002FCT",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","Patients will be intravenously injected with Al18F-PSMA-BCH and undergo PET\u002FCT scan.",[9],[20],"18F-Thretide PET\u002FCT",[22],{"name":23,"affiliation":24,"role":25},"Rong Zheng, MD","National Cancer Center\u002FCancer Hospital,Chinese Academy of Medical Sciences and PUMC","PRINCIPAL_INVESTIGATOR",[27,33],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Xin Cheng, MD","CONTACT","15120002998",null,"cxpumc@foxmail.com",{"name":34,"role":29,"phone":35,"phoneExt":31,"email":36},"Guozhu Hou, MD","15611145656","15611145656@163.com",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"National Cancer Center\u002FCancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College","RECRUITING","Beijing","Chaoyang","100029","China","CN",{"type":47,"coordinates":48},"Point",[49,50],116.39723,39.9075,{"lat":50,"lon":49},[53],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},{"type":55,"investigatorFullName":31,"investigatorTitle":31,"investigatorAffiliation":31,"oldNameTitle":31,"oldOrganization":31},"SPONSOR","100497755","phase-2-application-of-18f-psma-pet--ct-imaging-in-prostate-specific-membrane-antigen-positive-tumor-100497755",false,"NCT05761366","Application of 18F-PSMA PET \u002F CT Imaging in Prostate Specific Membrane Antigen Positive Tumor","Inclusion Criteria:\n\n1. Patients with suspected or clearly diagnosed PSMA positive-expressing tumors, including prostate cancer, transitional epithelial carcinoma, colon carcinoma, adenoid cystadenocarcinoma, mesothelioma, hepatocellular carcinoma, cholangiocellular carcinoma, multiple myeloma, etc.\n2. Age is 18 or older; No gender limitation.\n3. Signed the informed consent.\n4. Willing and able to cooperate with all projects in this study.\n\nExclusion Criteria:\n\n1. Patients with serious neurological diseases,or gastrointestinal tract disease, cardiovascular disease, liver disease, kidney disease, blood system disease, endocrine system disease, respiratory system disease, immune deficiency disease, etc\n2. Claustrophobia.\n3. Pregnant or lactation women.\n4. Received experimental drug or device within 1 month.","ALL","18 Years",{"count":65,"type":66},400,"ESTIMATED","INTERVENTIONAL",[69],"PHASE2","In this study, Al18F-PSMA-BCH PET\u002FCT will be performed in patients with prostate specific membrane antigen positive tumor, to evaluate the tumour detection efficacy of Al18F-PSMA-BCH PET\u002FCT.",[72],"Malignancy",[72,74],"Prostate Specific Membrane Antigen Positive Tumor","2024-12-21",{"date":77,"type":78},"2024-12-27","ACTUAL",{"date":80,"type":78},"2022-10-13",{"date":82,"type":66},"2025-10-13",{"name":5,"class":6},1]